Literature DB >> 21563050

[Time required and associated costs for implementation of home medication review with associated pharmaceutical and medical evaluation in the ambulatory health care sector].

T Fiß1, M Schaefer, N van den Berg, W Hoffmann.   

Abstract

INTRODUCTION: We aimed to estimate the time which is needed to conduct a home medication review (HMR) in the context of the AGnES implementation studies (AGnES=GP-supporting, community-based, e-health-assisted, systemic intervention). In a subsequent step associated costs were calculated.
METHODS: IT-supported HMR were conducted by specially qualified AGnES-practice assistants to detect selected drug-related problems (DRP). The patient received pharmaceutical care by their local pharmacist and medical evaluation by their GP, respectively.
RESULTS: The data from 471 patients (w: 339; m: 132) were evaluated (median age: w=81; m=78). The interview to detect selected DRP was 6 min (median) long. The subsequent drug record took 14.4 min. There was an additional effort for documentation of 5 min. The local pharmacist needed a median time of 15 min for pharmaceutical evaluation, whereas the GP needed 8 min. The estimated costs accounted for: AGnES-practice assistant: 9.12 €; pharmacist: 11.05 €; GP: 6.30 €. The overall estimated costs were 26.47 €.
CONCLUSION: For the first time we present objective costs which were associated with the implementation of HMR. Due to high DRP-induced costs the HMR should be mandatory for groups with a high risk like for the occurrence of DRP. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21563050     DOI: 10.1055/s-0031-1275716

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  2 in total

1.  Effects of a three party healthcare network on the incidence levels of drug related problems.

Authors:  Thomas Fiß; Claudia Meinke-Franze; Neeltje van den Berg; Wolfgang Hoffmann
Journal:  Int J Clin Pharm       Date:  2013-07-14

2.  Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews.

Authors:  Raphael Sell; Marion Schaefer
Journal:  Int J Clin Pharm       Date:  2020-02-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.